CVS Health's Caremark and Cigna's Express Scripts — of "engaging in anticompetitive and unfair rebating practices that have ...

Increased risk of hyperglycemia of hypoglycemia if changes in physical activity, meal patterns, concomitant medications, renal or hepatic function, insulin regimen, administration site ...

Then, I compared 14 plans that have the same name across the country ... in the coverage of these drugs, which becomes an important concern for those who need insulin. There are probably 12 ...

Doescher: I just want to make sure I get that. Haislmaier: The drug, the list price goes up. Doescher: Yes. The price for my insulin goes up. Haislmaier: And you may be paying more as the patient ...

“Although not named in this case, all drug manufacturers should be ... adding that the company has not raised list prices for ...

Their medicines originally had monthly list prices set at hundreds of ... weekly at U.S. pharmacies which can get the drug ...

This “recombinant insulin” first came on the market in the mid-1980s, under the brand name Humulin. After its release, Humulin quickly replaced traditional sources of insulin. Today, almost all ...

I was informed that my diabetic insulin and one of my high blood pressure prescriptions ... Verify your “extra help” (based ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

In particular, the agency argued that the rebate practices of Caremark, Express Scripts, and OptumRx caused the list prices of insulin drugs to be artificially high and limited patients' access to ...

Drug giant Eli Lilly has announced a ... It is also dropping the list price of its non-branded insulin, Lispro, to $25 a vial, effective 1 May. "While the current healthcare system provides ...

Insulin 6x is a single ingredient drug in this case and writing ‘Insulin Tablets’ on the label imitating it as a proprietary name was in violation of the Drugs and Cosmetics Rules, 1945.